XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL INSTRUMENTS
6 Months Ended
Jun. 30, 2020
Investments, Debt and Equity Securities [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS
All marketable securities were classified as available-for-sale at June 30, 2020 and December 31, 2019.
The following tables show the Company’s cash, cash equivalents and available-for-sale securities by significant investment category for each period presented:
June 30, 2020
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Aggregate Fair ValueCash and Cash Equivalents
Short-term
Marketable
Securities (1)
Long-term
Marketable
Securities (2)
Level 1:
Cash$289,755  $—  $—  $289,755  $289,755  $—  $—  
Level 2:
Money market instruments348,757  —  —  348,757  348,757  —  —  
Corporate debt securities542,518  6,110  (54) 548,574  48,728  311,690  188,156  
Commercial paper192,267   (1) 192,270  120,662  71,608  —  
U.S. government agency securities295,600  2,824  —  298,424  10,998  175,862  111,564  
Asset-backed securities24,769  180  (3) 24,946  —  2,312  22,634  
Foreign and other549  156  (1) 704  —  —  704  
Subtotal1,404,460  9,274  (59) 1,413,675  529,145  561,472  323,058  
Total$1,694,215  $9,274  $(59) $1,703,430  $818,900  $561,472  $323,058  


December 31, 2019
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Aggregate Fair ValueCash and Cash Equivalents
Short-term
Marketable
Securities (1)
Long-term
Marketable
Securities (2)
Level 1:
Cash$259,347  $—  $—  $259,347  $259,347  $—  $—  
Level 2:
Money market instruments173,100  —  —  173,100  173,100  —  —  
Corporate debt securities518,523  3,575  (12) 522,086  —  233,294  288,792  
U.S. government agency securities209,633  993  (67) 210,559  4,999  83,067  122,493  
Foreign and other549  145  (1) 693  —  —  693  
Subtotal901,805  4,713  (80) 906,438  178,099  316,361  411,978  
Total$1,161,152  $4,713  $(80) $1,165,785  $437,446  $316,361  $411,978  
(1) The Company’s short-term marketable securities mature in one year or less.
(2) The Company’s long-term marketable securities mature between one and five years.
As of June 30, 2020, the Company had the ability and intent to hold all investments that were in an unrealized loss position until maturity or recovery. The Company considered the extent to which fair value is less than amortized cost basis, conditions specifically related to the security’s industry and geography, payment structure and history and changes to the ratings (if any) in determining that the decline in fair value compared to carrying value is not related to a credit loss.
The Company has three investments in non-marketable equity securities, measured using unobservable valuation inputs remeasured on a nonrecurring basis, which are collectively considered strategic investments. As of June 30, 2020 and December 31, 2019, the fair value of the Company’s strategic investments was $6.2 million. These investments were recorded in Other Assets in the Company’s Condensed Consolidated Balance Sheets.